Published in J Exp Med on January 01, 1983
Immunoglobulin D as a lymphocyte receptor. J Exp Med (1973) 4.62
Similar idiotypic specificity for the membrane IgD and IgM of human B lymphocytes. J Immunol (1975) 2.28
Extracellular idiotypic immunoglobulin arising from human leukemic B lymphocytes. J Exp Med (1980) 1.57
Different species of messenger RNA encode receptor and secretory IgM mu chains differing at their carboxy termini. Nature (1980) 1.51
Expression of IgD may use both DNA rearrangement and RNA splicing mechanisms. Proc Natl Acad Sci U S A (1981) 1.48
Light chain types in plasma cells that produce IgD. Immunology (1969) 1.23
Cell surface phenotype in lymphoproliferative disease. Am J Med (1980) 1.13
A study of immunoglobulin classes present on the membrane and in the cytoplasm of human tonsil plasma cells. Eur J Immunol (1976) 1.04
The structure and biology of human IgD. Immunol Rev (1977) 1.01
Immunoglobulin produced by guinea-pig leukaemic B lymphocytes: its source and use as a monitor of tumour load. Immunology (1980) 0.94
The nature of the immunoglobulin G on the surface of B lymphocytes in chronic lymphocytic leukemia. J Exp Med (1981) 0.94
Characterization of IgD. II. Molecular forms of IgD in human B cells. Scand J Immunol (1979) 0.89
Biogenesis of membrane-bound and secreted immunoglobulins: two primary translation products of the human delta chain, differentially N-glycosylated to four discrete forms in vivo and in vitro. Proc Natl Acad Sci U S A (1981) 0.89
Biosynthesis and characterization of intracellular IgDkappa in a case of CLL. Clin Exp Immunol (1977) 0.86
Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood (1999) 11.50
CD40 antibody evokes a cytotoxic T-cell response that eradicates lymphoma and bypasses T-cell help. Nat Med (1999) 2.61
DNA vaccines with single-chain Fv fused to fragment C of tetanus toxin induce protective immunity against lymphoma and myeloma. Nat Med (1998) 1.83
Myeloma VL and VH gene sequences reveal a complementary imprint of antigen selection in tumor cells. Blood (1997) 1.73
Antibody to a molecularly-defined antigen confined to a tumour cell surface. Nature (1975) 1.61
Extracellular idiotypic immunoglobulin arising from human leukemic B lymphocytes. J Exp Med (1980) 1.57
Nucleotide sequence analysis of the V regions of two IgM cold agglutinins. Evidence that the VH4-21 gene segment is responsible for the major cross-reactive idiotype. J Immunol (1991) 1.56
The recombination of dimers of immunoglobulin peptide chains. Biochem J (1970) 1.54
VH restriction among human cold agglutinins. The VH4-21 gene segment is required to encode anti-I and anti-i specificities. J Immunol (1992) 1.52
Anti-idiotype sera raised against surface immunoglobulin of human neoplastic lymphocytes. J Exp Med (1976) 1.41
Surface immunoglobulin of guinea-pig leukaemic lymphocytes. Immunology (1975) 1.36
Preparation and performance of bispecific F(ab' gamma)2 antibody containing thioether-linked Fab' gamma fragments. J Immunol (1987) 1.35
Immunoglobulin V genes and CD38 expression in CLL. Blood (2000) 1.30
Immunogenetic analysis of the immune response to pneumococcal polysaccharide. Eur J Immunol (2000) 1.28
Idiotypic determinants on the surface immunoglobulin of neoplastic lymphocytes: a therapeutic target. Fed Proc (1977) 1.25
Preliminary experience in treating lymphocytic leukaemia with antibody to immunoglobulin idiotypes on the cell surfaces. Br J Cancer (1980) 1.25
Some effects on leukaemic B lymphocytes of antibodies to defined regions of their surface immunoglobulin. Immunology (1977) 1.21
Protein-polysaccharide complexes secreted by the calf tracheal epithelium in vitro. Biochem J (1969) 1.19
Antibody activity in the presence of urea or guanidine. Biochim Biophys Acta (1967) 1.19
Characterization of a new monoclonal anti-Fc gamma RII antibody, AT10, and its incorporation into a bispecific F(ab')2 derivative for recruitment of cytotoxic effectors. Mol Immunol (1991) 1.14
Analysis of VH genes used by neoplastic B cells in endemic Burkitt's lymphoma shows somatic hypermutation and intraclonal heterogeneity. Blood (1995) 1.11
Pharmacological inhibitors of NF-kappaB accelerate apoptosis in chronic lymphocytic leukaemia cells. Oncogene (2006) 1.08
Anti-idiotypic mechanisms involved in suppression of a mouse B cell lymphoma, BCL1. J Immunol (1987) 1.08
The I binding specificity of human VH 4-34 (VH 4-21) encoded antibodies is determined by both VH framework region 1 and complementarity determining region 3. J Mol Biol (1996) 1.08
Differential rates of somatic hypermutation in V(H) genes among subsets of chronic lymphocytic leukemia defined by chromosomal abnormalities. Blood (1997) 1.07
Molecular characterization of a cross-reactive idiotope on human immunoglobulins utilizing the VH4-21 gene segment. J Exp Med (1993) 1.07
Analysis of immunoglobulin E VH transcripts in a bronchial biopsy of an asthmatic patient confirms bias towards VH5, and indicates local clonal expansion, somatic mutation and isotype switch events. Immunology (1999) 1.06
Antibodies to shared idiotypes as agents for analysis and therapy for human B cell tumors. Blood (1986) 1.05
Recovery of immunoglobulin removed from lymphocytic surfaces by proteolysis. Immunology (1974) 1.04
Analysis of the interaction of antibodies with immunoglobulin idiotypes on neoplastic B lymphocytes: implications for immunotherapy. J Immunol (1987) 1.02
Bispecific F(ab' gamma)2 antibody for the delivery of saporin in the treatment of lymphoma. J Immunol (1988) 1.02
CD2 antigen mediated activation of the guanine nucleotide binding proteins p21ras in human T lymphocytes. J Immunol (1991) 1.02
A gamma Bence-Jones protein in guinea pigs. Biochem J (1975) 1.02
Analysis of soluble HLA class II antigenic material in patients with immunological diseases using monoclonal antibodies. J Immunol Methods (1986) 1.02
Ig VH gene mutational patterns indicate different tumor cell status in human myeloma and monoclonal gammopathy of undetermined significance. Blood (1996) 0.99
Pattern of usage and somatic hypermutation in the V(H)5 gene segments of a patient with asthma: implications for IgE. Eur J Immunol (1997) 0.99
Triggering Fc alpha-receptor I (CD89) recruits neutrophils as effector cells for CD20-directed antibody therapy. J Immunol (2000) 0.98
Human monoclonal antibodies against blood group antigens preferentially express a VH4-21 variable region gene-associated epitope. Scand J Immunol (1991) 0.98
Tracking of the V4-34 (VH4-21) gene in human tonsil reveals clonal isotype switch events and a highly variable degree of somatic hypermutation. Clin Exp Immunol (1996) 0.98
HLA class II as potential target antigen on malignant B cells for therapy with bispecific antibodies in combination with granulocyte colony-stimulating factor. Blood (1996) 0.97
Human antilipid A monoclonal antibodies bind to human B cells and the i antigen on cord red blood cells. J Immunol (1993) 0.97
Specific dimerization of the light chains of human immunoglobulin. Biochem J (1968) 0.97
DNA fusion vaccine designed to induce cytotoxic T cell responses against defined peptide motifs: implications for cancer vaccines. J Immunol (2001) 0.97
Autoanti-red cell antibodies synthesized by patients with infectious mononucleosis utilize the VH4-21 gene segment. J Immunol (1993) 0.97
Immunoglobulin negative follicle centre cell lymphoma. Br J Cancer (1984) 0.97
Insight into Burkitt's lymphoma from immunoglobulin variable region gene analysis. Leuk Lymphoma (1998) 0.97
DNA vaccines against lymphoma: promotion of anti-idiotypic antibody responses induced by single chain Fv genes by fusion to tetanus toxin fragment C. J Immunol (1997) 0.95
Plant viral genes in DNA idiotypic vaccines activate linked CD4+ T-cell mediated immunity against B-cell malignancies. Nat Biotechnol (2001) 0.95
Further studies of immunoglobulin synthesis by guinea pig leukaemic lymphocytes. Immunology (1978) 0.95
Immunoglobulin produced by guinea-pig leukaemic B lymphocytes: its source and use as a monitor of tumour load. Immunology (1980) 0.94
The effect of ions on the viscometric and ultracentrifugal behaviour of Tamm-Horsfall glycoprotein. Biochim Biophys Acta (1971) 0.94
Tumor cells of hairy cell leukemia express multiple clonally related immunoglobulin isotypes via RNA splicing. Blood (2001) 0.94
Examples of in vivo isotype class switching in IgM+ chronic lymphocytic leukemia B cells. J Clin Invest (1996) 0.94
The nature of the immunoglobulin G on the surface of B lymphocytes in chronic lymphocytic leukemia. J Exp Med (1981) 0.94
Prospects for the treatment of B cell tumors using idiotypic vaccination. Int Rev Immunol (1989) 0.94
Evaluating antibodies for their capacity to induce cell-mediated lysis of malignant B cells. Cancer Res (1998) 0.93
Validation of an ELISA for the determination of rituximab pharmacokinetics in clinical trials subjects. J Immunol Methods (2010) 0.93
Detection in normal plasma of immunoglobulin resembling the protein of gamma-chain disease. Nature (1973) 0.93
The problem of hapten persistently bound to antibody. Biochem J (1970) 0.93
Therapeutic efficacy of FcgammaRI/CD64-directed bispecific antibodies in B-cell lymphoma. Blood (2000) 0.92
Rapid cytotoxicity of human B lymphocytes induced by VH4-34 (VH4.21) gene-encoded monoclonal antibodies, II. Clin Exp Immunol (1997) 0.92
Antibodies against urinary light chain idiotypes as agents for detection and destruction of human neoplastic B lymphocytes. J Immunol (1983) 0.92
Preliminary studies for an immunotherapeutic approach to the treatment of human myeloma using chimeric anti-CD38 antibody. Blood (1991) 0.92
VH and VL gene analysis in sporadic Burkitt's lymphoma shows somatic hypermutation, intraclonal heterogeneity, and a role for antigen selection. Blood (1996) 0.92
Cross-linking of lymphocytic surface immunoglobulin inhibits its production via a cyclic nucleotide mechanism. Nature (1979) 0.92
Selective expression of a VHIV subfamily of immunoglobulin genes in human CD5+ B lymphocytes from cord blood. J Exp Med (1991) 0.91
The specificity of a solid phase radioimmunoassay for human immunoglobulins. J Immunol Methods (1975) 0.91
Antigenic modulation of lymphocytic surface immunoglobulin yielding resistance to complement-mediated lysis. II. Relationship to redistribution of the antigen. Immunology (1981) 0.91
Dual recognition of lipid A and DNA by human antibodies encoded by the VH4-21 gene: a possible link between infection and lupus. Hum Antibodies Hybridomas (1995) 0.91
Structural analysis of VH4-21 encoded human IgM allo- and autoantibodies against red blood cells. Scand J Immunol (1995) 0.91
Manipulation of pathogen-derived genes to influence antigen presentation via DNA vaccines. Vaccine (1999) 0.91
CD40 ligation for immunotherapy of solid tumours. J Immunol Methods (2001) 0.90
Universal N-glycosylation sites introduced into the B-cell receptor of follicular lymphoma by somatic mutation: a second tumorigenic event? Leukemia (2006) 0.90
Subunits of Tamm-Horsfall glycoprotein. Biochem J (1970) 0.90
A human b-cell lymphoma synthesizing and expressing surface mu-chain in the absence of detectable light chain. Blood (1981) 0.90
Rapid cytotoxicity of human B lymphocytes induced by VH4-34 (VH4.21) gene-encoded monoclonal antibodies. Clin Exp Immunol (1996) 0.90
Analysis of Ig VH region genes encoding IgE antibodies in splenic B lymphocytes of a patient with asthma. J Immunol (1995) 0.90